Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil
New five-year agreement delivers critical academic and life sciences insights into more than 400 institutions, broadening access and driving national research excellence
LONDON, June 2, 2025 /CNW/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the renewal of its multi-year partnership with CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), significantly expanding access to trusted Academia & Government and Life Sciences & Healthcare data across over 400 Brazilian institutions. As compared to the previous contract, the agreement increases institutional coverage by 57%, extending the reach of high-quality research tools to universities and research centers across Brazil — from major metropolitan areas to the country's most remote regions.
As a key agency under Brazil's Ministry of Education, CAPES plays a vital role in advancing postgraduate education, supporting high-level training, and fostering international scientific collaboration. A long-standing partner to CAPES, Clarivate began its collaboration with the agency in 2001, when the Web of Science became one of the first databases integrated into the CAPES Portal. This new agreement builds on that legacy, delivering enhanced access to solutions including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence and Derwent Innovation Index.
By bringing together world-class data and insights from academic research and the life sciences and healthcare sectors, the agreement empowers researchers and practitioners at all levels — including scholars, policy advisors, biomedical scientists and healthcare professionals — to conduct innovative research, develop new treatments, improve patient care, and inform policy decisions. It provides broad access to critical information, advancing evidence-based discovery, education and decision-making across disciplines.
Matti Shem Tov, Chief Executive Officer, Clarivate, said: "This expanded partnership with CAPES is a powerful example of how strategic collaboration can accelerate research and innovation on a national scale. Brazil has made remarkable progress in advancing scientific excellence and global collaboration. We're proud to support this momentum by providing trusted data, insights, and technology to researchers across the country — from early discovery through impact assessment. Our shared commitment to expanding access and fostering innovation will continue to shape the future of research in Brazil and beyond."
Denise Pires de Carvalho, President, CAPES, said: "Brazil is experiencing a moment of growing scientific output beyond its major urban centers, with resources now being distributed in a more equitable and democratic way to boost productivity across all regions. This collaboration with Clarivate enables us to better understand the scientific production profile of Brazilian institutions and supports more informed investment decisions to reduce regional disparities, which remains a significant national challenge. Many researchers in the North, Northeast and Center-West have limited access to the resources needed to give visibility to their work and expanding that access can make a meaningful difference."
The renewed partnership reflects a shared commitment to democratizing access to critical scientific information and enabling data-driven research excellence. Through Web of Science, Journal Citation Reports, and Derwent Innovation Index, academic institutions and government agencies gain deeper visibility into global research trends, publication impact, and innovation pathways — supporting policy development, institutional benchmarking, and scholarly advancement.
Complementing these capabilities, expanded access to Cortellis Drug Discovery Intelligence equips Brazil's life sciences community — including postgraduate students, faculty, and biomedical researchers — with comprehensive insights across biology, pharmacology, and chemistry. From disease understanding and drug interactions to clinical studies and intellectual property, users can more efficiently navigate the full R&D lifecycle and accelerate decision-making in high-impact research areas.
By significantly expanding access to trusted research and innovation tools, this agreement supports CAPES' mission to reduce regional disparities and foster inclusive academic excellence. Institutions from across Brazil — from leading urban universities to those in underserved and remote regions — can now leverage high-quality data to strengthen postgraduate programs, accelerate innovation, and elevate the global visibility of Brazilian research.
Clarivate values its collaboration with CAPES on this initiative to help shape a more connected, informed and future-ready research ecosystem across Brazil, and stands as a resource for academic consortia worldwide seeking to expand access to trusted research, data and insights.
To learn more about this partnership and the solutions now available to CAPES institutions, visit here.
Notes to editors
According to the most recent Institute for Scientific Information G20 research and innovation scorecard:
Around 40% of Brazilian research output is internationally collaborative, with many strong bilateral partnerships with the United States. It also participates in larger collaborations involving the U.S., the U.K., Spain, Germany, and France. Compared with other internationally collaborative output, these partnerships are producing papers with above average impact.
Its research output shows a strong focus on Sustainable Development Goals (SDGs) Zero Hunger (SDG 2) and Life on Land (SDG 15), with impact for both around 0.7 to 0.8 times the world average.
More broadly, Brazilian research output has a strong focus on the Life Sciences, while its output in Medicine has impact around 1.1 times the world average.
Around 40% of output is published in open access (OA) journals, with their Humanities and Languages output 2.4 times more likely to be published in an OA journal than the G20 average.
About ClarivateClarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
About Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) is a consortium dedicated to expanding and strengthening postgraduate studies in Brazil. It ensures the quality of academic programs while fostering the development of highly qualified professionals in research, teaching, and other strategic scientific fields.
Media contacts:
Clarivate
Rebecca KrahenbuhlSenior Manager, External Communications – Academia & Governmentnewsroom@clarivate.com
Catherine DanielDirector, External Communications – Life Sciences & Healthcarenewsroom@clarivate.com
CAPESJoão Mendes Communications joao.mendes@capes.gov.br
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-and-capes-expand-landmark-partnership-to-power-research-and-innovation-across-brazil-302469715.html
SOURCE Clarivate Plc
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2025/02/c5765.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
31 minutes ago
- Forbes
Healthy, Healed Kenny Clark Hoping For Bounceback Season With Packers
Green Bay Packers defensive tackle Kenny Clark (97) suffered a foot injury in Week 1 last year that ... More needed surgery after the season. Green Bay Packers defensive tackle Kenny Clark had arguably the worst of his nine NFL seasons in 2024. And afterwards, many questioned if Clark's terrific career was nearing the end. Maybe not. Turns out Clark played virtually the entire season with a right foot injury that slowed him throughout and needed to be surgically repaired in January. 'It was tough,' Clark said. 'It was a tough year for me.' Clark suffered the injury during the Packers' Week 1 loss to Philadelphia in São Paulo, Brazil. Afterwards, Clark was critical of the field conditions at Arena Corinthians, where the game was held. 'It was trash, man,' Clark said. 'I've played in snow. I've played in rain. I ain't never played on a surface like that. There was like clay coming out of the ground. You got holes in the ground. It was a tough surface to play on.' Playing the rest of the season with a foot injury was also brutal for Clark. Clark described the injury as 'like a bunion, bone spurs.' And it dramatically affected his production. Clark's 37 tackles were his fewest since his rookie season in 2016, when he started just two games. His one sack and five quarterback hits were also his fewest since 2016. 'You're taking every step and the toe is busting,' Clark said. 'It's something you've got to deal with, but it is what it is. That's done. I got the surgery done, and yeah, we're moving forward.' If the Packers can get Clark back on track, their inconsistent defensive line could take a step up in 2025. Clark had a career-high 7.5 sacks in 2023, which ranked third on the team. Clark also led the Packers with nine tackles for loss that season. Clark added 16 quarterback hits, had two forced fumbles, three passes defensed and didn't miss a game in 2023. Green Bay's pass defense was 0.51 yards per play better when Clark on the field in 2023, and its run defense was 0.18 yards per play better with Clark playing. Clark earned his third trip to the Pro Bowl that season, joining Henry Jordan (1960-61, 1963, 1966) as the only Packers defensive tackles to make three-plus Pro Bowls. Green Bay then signed Clark to a three-year, $64 million contract in July, 2024. 'He is a model player that you kind of want to build a program around,' Packers general manager Brian Gutekunst said of Clark. 'Obviously he's a great player, has been as consistent as you could ever imagine. We're just really excited to kind of be able to extend him and let him lead that group for the foreseeable future.' After a subpar 2024, though, many wondered if Clark had hit the wall. Now, Clark and the Packers are hoping better health leads to a big 2025. 'Yeah, I'm excited. I'm so excited to play ball,' Clark said. 'Like I said, it's going to be a huge year, I'm excited about it.'
Wall Street Journal
2 hours ago
- Wall Street Journal
Some of Trump's Biggest Inaugural Donors Benefit From Early Government Actions
The biggest contributor to President Trump's inauguration was chicken processor Pilgrim's Pride, which gave $5 million. In April, its Brazilian parent company, JBS, received government approval for a U.S. stock listing that it had long sought. The second largest donor was the cryptocurrency company Ripple, which gave about $4.9 million. In May it reached a settlement with the Securities and Exchange Commission to resolve a long-running lawsuit, sending its coin soaring.
Washington Post
4 hours ago
- Washington Post
Peru allows miners to seek permits in area removed from Nazca Lines protection
BOGOTA, Colombia — Peru announced Tuesday that miners who had been operating illegally in a large protected archaeological reserve around the famous Nazca Lines will now be able to start the process of obtaining mining permits, after the government reduced the protected area by 42%. Energy and Mines Minister Jorge Montero said those working in the area must now legalize their mining activities since the zone is no longer designated as archaeological heritage.
